{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T20:04:39Z","timestamp":1785355479430,"version":"3.55.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014932","name":"Ascend Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014932","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obstetrics and Gynecology Clinics of North America"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ogc.2026.03.003","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:03:59Z","timestamp":1778756639000},"page":"393-410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Testosterone in Women"],"prefix":"10.1016","volume":"53","author":[{"given":"Jennifer","family":"Lanoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ogc.2026.03.003_bib1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/13697130902973227","article-title":"The role of testosterone in women","volume":"12","author":"Panay","year":"2009","journal-title":"Climacteric"},{"issue":"Suppl 1","key":"10.1016\/j.ogc.2026.03.003_bib2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3109\/13697137.2013.801736","article-title":"Androgen therapy in women, beyond libido","volume":"16","author":"Davis","year":"2013","journal-title":"Climacteric"},{"issue":"11","key":"10.1016\/j.ogc.2026.03.003_bib3","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1210\/jc.2019-01357","article-title":"Androgens during the reproductive years: what is normal for women?","volume":"104","author":"Skiba","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2026.03.003_bib4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1210\/rp.57.1.257","article-title":"Hormonal changes in the menopause transition","volume":"57","author":"Burger","year":"2002","journal-title":"Recent Prog Horm Res"},{"issue":"4","key":"10.1016\/j.ogc.2026.03.003_bib5","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1210\/er.2017-00025","article-title":"A reappraisal of testosterone\u2019s binding in circulation: physiological and clinical implications","volume":"38","author":"Goldman","year":"2017","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ogc.2026.03.003_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105972","article-title":"Testosterone and pre-androgens by age and menopausal stage at midlife: findings from a cross-sectional study","volume":"121","author":"Wang","year":"2025","journal-title":"EBioMedicine"},{"issue":"17","key":"10.1016\/j.ogc.2026.03.003_bib7","doi-asserted-by":"crossref","DOI":"10.1172\/JCI180073","article-title":"Metabolic benefits afforded by estradiol and testosterone in both sexes: clinical considerations","volume":"134","author":"Mauvais-Jarvis","year":"2024","journal-title":"J Clin Investig"},{"key":"10.1016\/j.ogc.2026.03.003_bib8","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/jsxmed\/qdae032","article-title":"Testosterone therapy in females is not associated with increased cardiovascular or breast cancer risk: a claims database analysis","volume":"21","author":"Agrawal","year":"2024","journal-title":"J Sex Med"},{"key":"10.1016\/j.ogc.2026.03.003_bib9","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jsxm.2020.10.009","article-title":"International Society for the Study of Women\u2019s Sexual Health clinical practice guideline for the use of systemic testosterone for hypoactive sexual desire disorder in women","volume":"18","author":"Parish","year":"2021","journal-title":"J Sex Med"},{"issue":"5","key":"10.1016\/j.ogc.2026.03.003_bib10","first-page":"421","article-title":"Sexual dysfunction among women of reproductive age: a systematic review and meta-analysis","volume":"19","author":"Alidost","year":"2021","journal-title":"Int J Reprod Biomed"},{"issue":"5","key":"10.1016\/j.ogc.2026.03.003_bib11","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jsxm.2017.03.254","article-title":"Prevalence and predictors of low sexual desire, sexually related personal distress, and hypoactive sexual desire dysfunction in a community-based sample of midlife women","volume":"14","author":"Worsley","year":"2017","journal-title":"J Sex Med"},{"issue":"13","key":"10.1016\/j.ogc.2026.03.003_bib12","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1001\/archinte.168.13.1441","article-title":"Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of US women","volume":"168","author":"West","year":"2008","journal-title":"Arch Intern Med"},{"issue":"9","key":"10.1016\/j.ogc.2026.03.003_bib13","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.jsxm.2019.07.012","article-title":"Global consensus position statement on the use of testosterone therapy for women","volume":"16","author":"Davis","year":"2019","journal-title":"J Sex Med"},{"key":"10.1016\/j.ogc.2026.03.003_bib14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jsbmb.2013.05.006","article-title":"Androgen treatment of postmenopausal women","volume":"142","author":"Davis","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"10.1016\/j.ogc.2026.03.003_bib15","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/01.gme.0000243567.32828.99","article-title":"Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 study","volume":"13","author":"Shifren","year":"2006","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.ogc.2026.03.003_bib16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1089\/jwh.2018.7494","article-title":"Androgen therapy in women","volume":"29","author":"Vegunta","year":"2020","journal-title":"J Womens Health (Larchmt)"},{"issue":"1","key":"10.1016\/j.ogc.2026.03.003_bib17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ecl.2020.11.002","article-title":"Use of testosterone in postmenopausal women","volume":"50","author":"Davis","year":"2021","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"1","key":"10.1016\/j.ogc.2026.03.003_bib18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1001\/jama.294.1.91","article-title":"Circulating androgen levels and self-reported sexual function in women","volume":"294","author":"Davis","year":"2005","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.ogc.2026.03.003_bib19","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/GME.0000000000002613","article-title":"Challenges in developing accurate assays for the measurement of estradiol and testosterone in postmenopausal women","volume":"32","author":"Stanczyk","year":"2025","journal-title":"Menopause"},{"key":"10.1016\/j.ogc.2026.03.003_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/13697137.2023.2250252","article-title":"Testosterone and the heart: friend or foe?","volume":"27","author":"Davis","year":"2024","journal-title":"Climacteric"},{"issue":"5","key":"10.1016\/j.ogc.2026.03.003_bib21","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/AOG.0b013e3181898cdb","article-title":"Sexual problems and distress in United States women: prevalence and correlates","volume":"112","author":"Shifren","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"14","key":"10.1016\/j.ogc.2026.03.003_bib22","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/archinte.165.14.1582","article-title":"Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial","volume":"165","author":"Braunstein","year":"2005","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.ogc.2026.03.003_bib23","doi-asserted-by":"crossref","first-page":"569","DOI":"10.7326\/0003-4819-148-8-200804150-00001","article-title":"Safety and efficacy of a testosterone metered-dose transdermal spray for treating decreased sexual satisfaction in premenopausal women: a randomized trial","volume":"148","author":"Davis","year":"2008","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.ogc.2026.03.003_bib24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/09513590.2010.487597","article-title":"Safety and tolerability of testosterone patch therapy for up to 4 years in surgically menopausal women receiving oral or transdermal oestrogen","volume":"27","author":"Nachtigall","year":"2011","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"10.1016\/j.ogc.2026.03.003_bib25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2215025","article-title":"Cardiovascular safety of testosterone-replacement therapy","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ogc.2026.03.003_bib26","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S2213-8587(19)30189-5","article-title":"Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data","volume":"7","author":"Islam","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"10.1016\/j.ogc.2026.03.003_bib27","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1210\/jc.2014-2262","article-title":"Clinical review: the benefits and harms of systemic testosterone therapy in postmenopausal women with normal adrenal function: a systematic review and meta-analysis","volume":"99","author":"Elraiyah","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.ogc.2026.03.003_bib28","doi-asserted-by":"crossref","first-page":"e1515","DOI":"10.1210\/clinem\/dgad388","article-title":"Testosterone replacement therapy in relation with cardiovascular disease in cisgender women and transgender people","volume":"108","author":"Lopez","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ogc.2026.03.003_bib29","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1210\/jc.2004-1747","article-title":"Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder","volume":"90","author":"Simon","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2026.03.003_bib30","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-2265.2004.02125.x","article-title":"Testosterone increases bone mineral density in female-to-male transsexuals: a case series of 15 subjects","volume":"61","author":"Turner","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ogc.2026.03.003_bib31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0378-5122(94)00898-H","article-title":"Testosterone enhances estradiol\u2019s effects on postmenopausal bone density and sexuality","volume":"21","author":"Davis","year":"1995","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.ogc.2026.03.003_bib32","article-title":"A matched retrospective analysis: the relationship between testosterone replacement therapy and the incidence of hip fractures","volume":"33","author":"Peresuh","year":"2025","journal-title":"J Am Acad Orthop Surg"},{"issue":"3","key":"10.1016\/j.ogc.2026.03.003_bib33","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1210\/er.2003-0003","article-title":"Androgens and bone","volume":"25","author":"Vanderschueren","year":"2004","journal-title":"Endocr Rev"},{"issue":"4","key":"10.1016\/j.ogc.2026.03.003_bib34","first-page":"345","article-title":"Androgens and bone","volume":"30","author":"Clarke","year":"2009","journal-title":"Endocr Rev"},{"issue":"5","key":"10.1016\/j.ogc.2026.03.003_bib35","first-page":"801","article-title":"Sex steroids and the construction and conservation of the adult skeleton","volume":"17","author":"Riggs","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.ogc.2026.03.003_bib36","first-page":"389","article-title":"Estrogen and the skeleton","volume":"33","author":"Khosla","year":"2012","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ogc.2026.03.003_bib37","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/cen.14874","article-title":"Endogenous testosterone concentrations and muscle mass, strength and performance in women, a systematic review of observational studies","volume":"98","author":"Taylor","year":"2023","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"10.1016\/j.ogc.2026.03.003_bib38","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jsams.2022.08.005","article-title":"Association of handgrip strength with all-cause mortality: a nationally longitudinal cohort study in China","volume":"25","author":"Wang","year":"2022","journal-title":"J Sci Med Sport"},{"issue":"6","key":"10.1016\/j.ogc.2026.03.003_bib39","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/GME.0000000000000093","article-title":"Testosterone dose-response relationships in hysterectomized women with or without oophorectomy: effects on sexual function, body composition, muscle performance and physical function in a randomized trial","volume":"21","author":"Huang","year":"2014","journal-title":"Menopause"},{"issue":"5","key":"10.1016\/j.ogc.2026.03.003_bib40","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1210\/er.2018-00020","article-title":"Circulating testosterone as the hormonal basis of sex differences in athletic performance","volume":"39","author":"Handelsman","year":"2018","journal-title":"Endocr Rev"},{"issue":"11","key":"10.1016\/j.ogc.2026.03.003_bib41","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1080\/02640414.2016.1210197","article-title":"Dose-response relationship between weekly resistance training volume and increases in muscle mass: a systematic review and meta-analysis","volume":"35","author":"Schoenfeld","year":"2017","journal-title":"J Sports Sci"},{"issue":"2","key":"10.1016\/j.ogc.2026.03.003_bib42","first-page":"546","article-title":"Effects of testosterone on body composition and muscle protein synthesis in older men","volume":"87","author":"Ferrando","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ogc.2026.03.003_bib43","doi-asserted-by":"crossref","first-page":"192","DOI":"10.5534\/wjmh.180001","article-title":"Testosterone and sarcopenia","volume":"36","author":"Shin","year":"2018","journal-title":"World J Mens Health"},{"key":"10.1016\/j.ogc.2026.03.003_bib44","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/13697137.2022.2139600","article-title":"Association between testosterone and cognitive performance in postmenopausal women: a systematic review of observational studies","volume":"26","author":"Sultana","year":"2023","journal-title":"Climacteric"},{"key":"10.1016\/j.ogc.2026.03.003_bib45","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/cen.12459","article-title":"Transdermal testosterone improves verbal learning and memory in postmenopausal women not on oestrogen therapy","volume":"81","author":"Davis","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ogc.2026.03.003_bib46","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s40618-014-0213-3","article-title":"Effects of testosterone administration on cognitive function in hysterectomized women with low testosterone levels: a dose-response randomized trial","volume":"38","author":"Huang","year":"2015","journal-title":"J Endocrinol Investig"},{"key":"10.1016\/j.ogc.2026.03.003_bib47","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00737-024-01513-6","article-title":"Effect of transdermal testosterone therapy on mood and cognitive symptoms in peri- and postmenopausal women: a pilot study","volume":"28","author":"Glynne","year":"2025","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.ogc.2026.03.003_bib48","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.maturitas.2022.11.001","article-title":"The association between testosterone and depression in postmenopausal women: a systematic review of observational studies","volume":"168","author":"Hemachandra","year":"2023","journal-title":"Maturitas"},{"key":"10.1016\/j.ogc.2026.03.003_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.maturitas.2023.107822","article-title":"Associations between low sex hormone concentrations and depression in older women: an observational study","volume":"176","author":"Islam","year":"2023","journal-title":"Maturitas"},{"issue":"3","key":"10.1016\/j.ogc.2026.03.003_bib50","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/jsm.12426","article-title":"Testosterone improves antidepressant-emergent loss of libido in women: findings from a randomized, double-blind, placebo-controlled trial","volume":"11","author":"Fooladi","year":"2014","journal-title":"J Sex Med"},{"issue":"10","key":"10.1016\/j.ogc.2026.03.003_bib51","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1176\/appi.ajp.2020.19080844","article-title":"Low-dose testosterone augmentation for antidepressant-resistant major depressive disorder in women: an 8-Week randomized placebo-controlled study","volume":"177","author":"Dichtel","year":"2020","journal-title":"Am J Psychiatr"},{"issue":"9","key":"10.1016\/j.ogc.2026.03.003_bib52","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1507\/endocrj.EJ20-0178","article-title":"The applications of androgen in the treatment of dry eye disease: a systematic review of clinical studies","volume":"67","author":"Wang","year":"2020","journal-title":"Endocr J"},{"issue":"4","key":"10.1016\/j.ogc.2026.03.003_bib53","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.4103\/IJO.IJO_2887_22","article-title":"Hormones and dry eye disease","volume":"71","author":"Gorimanipalli","year":"2023","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.ogc.2026.03.003_bib54","first-page":"1553","article-title":"Do sex steroids exert sex-specific and\/or opposite effects on gene expression in lacrimal and meibomian glands?","volume":"15","author":"Sullivan","year":"2009","journal-title":"Mol Vis"},{"issue":"4","key":"10.1016\/j.ogc.2026.03.003_bib55","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/bjophthalmol-2013-304637","article-title":"Transdermal androgen patches in evaporative dry eye syndrome with androgen deficiency: a pilot study","volume":"98","author":"Nanavaty","year":"2014","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ogc.2026.03.003_bib56","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1080\/08164622.2025.2509586","article-title":"Topical androgen therapy: a potential advancement in treating post-menopausal dry eye","volume":"109","author":"Pandey","year":"2026","journal-title":"Clin Exp Optom"},{"key":"10.1016\/j.ogc.2026.03.003_bib57","first-page":"5608","article-title":"A multi-center, double-masked, randomized, vehicle-controlled, parallel group study to evaluate the safety and efficacy of testosterone ophthalmic solution in patients with meibomian gland dysfunction","volume":"47","author":"Schiffman","year":"2006","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.ogc.2026.03.003_bib58","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1007\/s11255-024-03996-9","article-title":"Associations between serum testosterone levels and overactive bladder in women: a cross-sectional research of NHANES 2011 to 2016","volume":"56","author":"Li","year":"2024","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"10.1016\/j.ogc.2026.03.003_bib59","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.juro.2017.08.093","article-title":"The Association of Serum testosterone levels and urinary incontinence in women","volume":"199","author":"Kim","year":"2018","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.ogc.2026.03.003_bib60","first-page":"1329","article-title":"Review of animal models to study urinary bladder function","volume":"40","author":"Seth","year":"2021","journal-title":"Neurourol Urodyn"},{"issue":"12","key":"10.1016\/j.ogc.2026.03.003_bib61","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1007\/s00345-023-04681-9","article-title":"Correlation of serum circulating testosterone levels with stress urinary incontinence in postmenopausal women","volume":"41","author":"Chen","year":"2023","journal-title":"World J Urol"},{"issue":"1","key":"10.1016\/j.ogc.2026.03.003_bib62","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ahj.2011.09.021","article-title":"A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disorder","volume":"163","author":"White","year":"2012","journal-title":"Am Heart J"},{"issue":"10","key":"10.1016\/j.ogc.2026.03.003_bib63","article-title":"Testosterone pellets in women: revisiting safety and clinical outcomes","volume":"17","author":"Viana","year":"2025","journal-title":"Cureus"},{"issue":"19","key":"10.1016\/j.ogc.2026.03.003_bib64","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1056\/NEJMoa0707302","article-title":"Testosterone for low libido in postmenopausal women not taking estrogen","volume":"359","author":"Davis","year":"2008","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ogc.2026.03.003_bib65","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jsxm.2020.01.009","article-title":"The Saga of testosterone for menopausal women at the Food and Drug Administration (FDA)","volume":"17","author":"Simon","year":"2020","journal-title":"J Sex Med"}],"container-title":["Obstetrics and Gynecology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854526000148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854526000148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:21:47Z","timestamp":1785352907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889854526000148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0889854526000148"],"URL":"https:\/\/doi.org\/10.1016\/j.ogc.2026.03.003","relation":{},"ISSN":["0889-8545"],"issn-type":[{"value":"0889-8545","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Testosterone in Women","name":"articletitle","label":"Article Title"},{"value":"Obstetrics and Gynecology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ogc.2026.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}